Discover the benefits of international dividend plays with HDEF, with a focus on Financials and Consumer Staples, offering ...

There is no statutory bar in the US for patenting drug-device combinations, including drug transdermal/thermal patches. In the US, patents for methods of treatment are also allowed. A list of a few ...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced the U.S. Food and Drug Administration (FDA) has approved MI Cancer Seektm for ...

AAPL earnings call for the period ending September 30, 2024.

Positive feedback received from US FDA regarding the planned TACTI-004 Phase III in first-line non-small cell lung cancer successfully concluding ...

Buccal Drug Delivery System market Size, Share, Revenue, Trends, and Drivers For 2024-2033. Buccal Drug Delivery System Market Size, Share, Revenue, Trends ...

Q4 2024 Earnings Call Transcript October 31, 2024 Apple Inc. beats earnings expectations. Reported EPS is $1.64, expectations ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide ...

An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug ...

Investment is flowing Big pharma has already noted its interest in the area, as seen in Novartis’ investments ... is Clarity Pharmaceuticals, an Australian company, which is developing ...

The government payor said it will separately pay for specialized diagnostic radiopharmaceuticals without transitional pass-through payment status.

Novartis (NVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Scala from ...